Antitumor mechanisms of OncoTherad nano- immunotherapy involving toll-like 4 recep...
Crosstalk Among T-Cells CX3CR1+, Immune Checkpoints and Monoamine Oxidases in Non-...
Effects of OncoTherad immunotherapy (MRB-CFI-1) on tumor progression and survival ...
New Therapeutic Approaches for Non-Muscle Invasive Bladder Cancer (NMIBC): Intrave...
Association of immunotherapy with OncoTherad® (MRB-CFI-1) and erythropoietin in th...
Association of Immunotherapy with OncoTherad® (MRB-CFI-1) and platelet-rich plasma...
Association of immunotherapy with OncoTherad® (MRB-CFI-1) and erythropoietin in th...